Build Muscle Faster than 90% of People in the Gym - Dr. Brad Schoenfeld’s Volume Strategy

Schoenfeld describes a clear dose-response relationship between sets and hypertrophy, with the first set providing the greatest stimulus and subsequent sets adding incrementally less. The consensus among researchers has gravitated toward 10–20 sets per muscle per week as a target range. However, he cautions that most studies involve limited muscle groups (e.g., chest, arms, legs) and total volumes around 100 sets for all exercises, which would be about 10 sets per muscle across the body. No studies have examined doing 20 sets for every single muscle group simultaneously, which might lead to systemic overreaching or overtraining at some point. This data gap supports the theoretical idea of periodizing volume to cycle higher and lower volume phases.

Schoenfeld explains that for lower volumes (≤8 sets per muscle per week), training that muscle once or twice per week yields similar results. But when the per-session volume climbs above 10 sets or so, the evidence starts showing an advantage to splitting the total volume over multiple sessions. He gives the example of 16 sets: doing 8 sets twice a week likely outperforms a single 16-set session. The proposed reasoning is that there is a per-session ceiling where additional sets produce progressively less stimulus and more fatigue, and splitting allows each session to provide a fresh 'first-set' like stimulus for that muscle. The 'clock reset' for when the muscle is ready for another high-quality bout is unclear, but twice a week seems effective.

Schoenfeld emphasizes that the old belief that high reps only build endurance and low reps only build strength is outdated; muscle growth can be achieved across a wide loading spectrum. He still recommends including some lower-rep heavy work and some higher-rep work, because training across the spectrum may have a synergistic effect. One proposed mechanism is that high-rep training (15–25+ reps) enhances intramuscular buffering capacity, which then allows better performance during moderate rep sets (e.g., getting a few extra reps). This concept stems from the idea that handling high acidosis improves the ability to tolerate and clear metabolites, thereby increasing effective volume in subsequent training.

Schoenfeld has long been interested in the pump, growing up in the 'pumping iron' era. Mechanistically, hydrating a muscle cell (cell swelling) in a test tube increases muscle protein synthesis and decreases breakdown — an 'anabolic home run'. However, translating this to living humans is difficult because it's nearly impossible to isolate the pump from other training effects. One study showed a correlation between the ability to get a pump in the first training session and long-term hypertrophy, though correlation isn't causation. Given the low downside, he advocates for including some pump-style training, especially for bodybuilders, as a potential synergistic addition. This aligns with a cost-benefit philosophy: if it might help and won't hurt, experiment with it.

Schoenfeld highlights a practical problem: lifters, especially those not accustomed to high-rep work, often underestimate how many more reps they could have done. Without the reference point of true failure, they might train too far from the necessary intensity. By taking a set to the point where they physically cannot complete another rep (with proper form), they learn what it feels like to be on the edge. Then, in subsequent training, they can aim to stop 1–2 reps before that point. This calibration is especially important when switching rep ranges, because the sensation of failure at 5 reps is different from failure at 25 reps.

Schoenfeld addresses the anxiety many lifters have about losing gains when life gets in the way. The literature is compelling that very low volumes — around 4 sets per muscle per week — are sufficient for maintaining muscle mass, even in well-trained individuals. This is a fraction of what is needed for growth. The mechanism may relate to the fact that maintaining existing myonuclei and protein structures requires less stimulus than building new ones. However, he notes that there are likely variables (starting muscle mass, recent training volume) that modulate this, but no direct studies answer those nuances. This finding is 'liberating' for those who can't train 4–6 days a week.

Schoenfeld describes how, as an up-and-coming sports scientist, the consensus was that training with sets above 12 reps was essentially cardiovascular exercise. The dogma held that heavy loads were needed to recruit type II fibers and produce hypertrophy, while higher reps failed to stimulate enough tension. Over the past decade, multiple studies using direct hypertrophy measures (MRI, etc.) have shown that when sets are taken close to failure, the rep range from as low as 6 to as high as 30 produces comparable whole-muscle growth. He credits his own research and that of others for this shift. He now considers the evidence 'pretty compelling'. This flexibility is liberating for average lifters and even bodybuilders; training across a spectrum of rep ranges may have additive benefits, perhaps by enhancing buffering capacity or causing different adaptive responses.

Schoenfeld explains that the emerging literature consistently shows that leaving a couple of repetitions in the tank produces essentially the same hypertrophic adaptations as grinding out failure reps. This does not mean training should be easy — effort must still be very high, with sets taken to within 1–2 reps of the absolute limit. He notes that high-rep training (30 reps to failure) is extremely painful and nauseating, but adaptation occurs over time. He also points out that to gauge proximity to failure accurately, lifters first need to experience true failure occasionally, so they know what it feels like. The implication is that for most sets, one can stay just shy of failure without losing gains, which may reduce injury risk and systemic fatigue.

Schoenfeld differentiates acute exercise-induced cortisol from chronic stress-induced cortisol. Chronic stress, with sustained high cortisol and inflammatory factors, acts as a negative regulator of growth. However, the transient cortisol surge after a training session is not only without evidence of harm, but it is the one hormone for which there is evidence of a positive correlation with hypertrophy. He cautions that correlation is not causation, but the data clearly show no negative effect. He speculates that the acute cortisol response may aid in tissue breakdown that sets up subsequent repair and growth, though the mechanism is unknown. This insight echoes the interviewer's implication that the fear of cortisol is overblown.

Schoenfeld explains that sarcoplasmic hypertrophy involves increases in non-contractile proteins (enzymes, T-tubules, etc.), which draw fluid into the cell due to the 3:1 fluid-to-protein ratio. This is distinct from the acute pump, which lasts only hours. He cites preliminary work from colleagues (Cody Horn, Mike Roberts) showing that higher-rep training may produce additional sarcoplasmic hypertrophy alongside normal contractile gains, resulting in greater total muscle size. He stresses that this does not mean less contractile growth — the evidence showed similar contractile hypertrophy plus extra sarcoplasmic growth. While sarcoplasmic gains might be somewhat more transient than contractile if training stops, they are still real gains. He warns against the 'slippery slope' of conflating the pump with sarcoplasmic hypertrophy.